Inhibitors of iNOS are currently under investigation in the context of the treatment of chronic inflammation, sepsis, as well as in neuroinflammatory diseases such as multiple sclerosis and Alzheimer’s disease, where chronic activation of microglia leads to NO-mediated neurotoxicity [33]. The gene discussed is NOS2; the disease is Sepsis.